Published online Apr 15, 2023. doi: 10.4239/wjd.v14.i4.364
Peer-review started: December 23, 2022
First decision: January 9, 2023
Revised: January 16, 2023
Accepted: March 21, 2023
Article in press: March 21, 2023
Published online: April 15, 2023
Processing time: 109 Days and 21.6 Hours
Wounds in diabetic patients, especially diabetic foot ulcers, are more difficult to heal compared with normal wounds and can easily deteriorate, leading to amputation. Common treatments cannot heal diabetic wounds or control their many complications. Growth factors are found to play important roles in regulating complex diabetic wound healing. Different growth factors such as transforming growth factor beta 1, insulin-like growth factor, and vascular endothelial growth factor play different roles in diabetic wound healing. This implies that a therapeutic modality modulating different growth factors to suit wound healing can significantly improve the treatment of diabetic wounds. Further, some current treatments have been shown to promote the healing of diabetic wounds by modulating specific growth factors. The purpose of this study was to discuss the role played by each growth factor in therapeutic approaches so as to stimulate further therapeutic thinking.
Core Tip: This review summarizes the main causes of poor wound healing in diabetes and the role of various therapeutically available growth factors in wound healing. In terms of treatment, it summarizes the treatment methods and drug delivery systems of various growth factors, and discusses the therapeutic effects of different methods and the special properties of drug delivery systems. We hope these discussions will provide the basis for more effective treatments, advance growth factor research, and help more people with diabetes heal their wounds.